Edoxaban Tosylate

CAS 480449-71-6

General Information

Edoxaban is an anti-clotting substance indicated to reduce the risk of stroke and systemic embolism (blood coagulation) in patients with nonvalvular atrial fibrillation (abnormal heart rhythm that is not caused by a heart valve problem).

Atrial fibrillation occurs when the heart’s two upper chambers (atria) do not contract properly, allowing formation of blood clots, which can travel to other parts of the body. Blood clots may cause stroke, heart attacks, and severe problems in other parts of the body.

Edoxaban tosylate monohydrate has also been approved for the treatment of deep vein thrombosis and pulmonary embolism in patients who have already been treated with an anti-clotting drug administered by injectable or infusion (parenterally), for five to ten days.

About the API

Technology Synthetic Organic Chemistry
Molecular Formula C31H38ClN7O7S2
Molecular Weight 720.3 g/mol
Therapeutic category Coagulation Inhibitors
Available formulations Oral Solid